As of 2025-07-10, the Intrinsic Value of Anshan Hifichem Co Ltd (300758.SZ) is 9.72 CNY. This 300758.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 14.65 CNY, the upside of Anshan Hifichem Co Ltd is -33.60%.
The range of the Intrinsic Value is 6.65 - 16.05 CNY
Based on its market price of 14.65 CNY and our intrinsic valuation, Anshan Hifichem Co Ltd (300758.SZ) is overvalued by 33.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 6.65 - 16.05 | 9.72 | -33.6% |
| DCF (Growth 10y) | 24.42 - 53.65 | 33.99 | 132.0% |
| DCF (EBITDA 5y) | 60.31 - 86.11 | 71.31 | 386.8% |
| DCF (EBITDA 10y) | 103.18 - 161.50 | 127.69 | 771.6% |
| Fair Value | 8.26 - 8.26 | 8.26 | -43.63% |
| P/E | 11.46 - 12.98 | 11.97 | -18.3% |
| EV/EBITDA | 10.18 - 14.29 | 12.13 | -17.2% |
| EPV | (3.45) - (3.78) | (3.62) | -124.7% |
| DDM - Stable | 2.24 - 5.59 | 3.92 | -73.3% |
| DDM - Multi | 12.73 - 24.28 | 16.67 | 13.8% |
| Market Cap (mil) | 5,948.49 |
| Beta | 1.28 |
| Outstanding shares (mil) | 406.04 |
| Enterprise Value (mil) | 6,863.26 |
| Market risk premium | 6.13% |
| Cost of Equity | 11.81% |
| Cost of Debt | 5.00% |
| WACC | 10.45% |